Barrington Research Predicts Henry Schein Q1 Earnings

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Barrington Research lowered their Q1 2025 earnings estimates for Henry Schein in a report issued on Wednesday, February 26th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $1.04 for the quarter, down from their prior forecast of $1.06. Barrington Research currently has a “Outperform” rating and a $90.00 price target on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein’s Q2 2025 earnings at $1.16 EPS, Q4 2025 earnings at $1.34 EPS, FY2025 earnings at $4.84 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.28 EPS, Q3 2026 earnings at $1.37 EPS, Q4 2026 earnings at $1.43 EPS, FY2026 earnings at $5.22 EPS and FY2027 earnings at $5.65 EPS.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the prior year, the firm posted $0.66 EPS. The firm’s quarterly revenue was up 5.8% on a year-over-year basis.

Several other brokerages have also recently issued reports on HSIC. UBS Group lowered their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Wells Fargo & Company started coverage on Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. Finally, Jefferies Financial Group boosted their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $72.17 on Thursday. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock has a market cap of $9.00 billion, a PE ratio of 29.70, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. The company’s 50-day moving average price is $74.35 and its two-hundred day moving average price is $72.42.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of HSIC. Palestra Capital Management LLC purchased a new stake in shares of Henry Schein in the fourth quarter worth approximately $182,988,000. Lyrical Asset Management LP acquired a new stake in shares of Henry Schein in the 4th quarter valued at $126,655,000. Norges Bank bought a new stake in shares of Henry Schein during the 4th quarter worth about $103,301,000. Steadfast Capital Management LP grew its holdings in Henry Schein by 254.2% during the fourth quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock valued at $113,336,000 after purchasing an additional 1,175,408 shares during the last quarter. Finally, ING Groep NV acquired a new position in Henry Schein in the 3rd quarter valued at $63,226,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.